# Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions

> **NCT00779831** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 120 mg Pseudoephedrine hydrochloride extended release tablets

## Key facts

- **NCT ID:** NCT00779831
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2004-06
- **Final completion:** 2004-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2008-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779831, "Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00779831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*